Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Novartis”
Sponsor: Novartis Pharmaceuticals
Mild Hypertension
Australia, New Zealand
- Long-term Follow-up of Patients With Spinal Muscular Atrophy Treated With OAV101 in Clinical TrialsActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Spinal Muscular Atrophy (SMA)
United States, Australia, Belgium, Brazil, Canada +14 more
Sponsor: Novartis Pharmaceuticals
Advanced EGFR Mutant Non Small Cell LungCancer (NSCLC) · KRAS G12-mutant NSCLC · Esophageal Squamous Cell Cancer (SCC) · Head/Neck SCC
United States, Canada, Italy, Japan, Netherlands +4 more
Sponsor: Novartis Pharmaceuticals
Multiple Myeloma
United States, Australia, Israel, Singapore
Sponsor: Novartis Pharmaceuticals
Advanced Breast Cancer
India
Sponsor: Novartis Pharmaceuticals
Acute Kidney Injury Following Cardiac Surgery
United States, Argentina, Belgium, Brazil, Canada +10 more
- A Global Study of Midostaurin in Combination With Chemotherapy to Evaluate Safety, Efficacy and Pharmacokinetics in Newly Diagnosed Pediatric Patients With FLT3 Mutated AMLActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
FLT3-mutated Acute Myeloid Leukemia
Czechia, Germany, Italy, Japan, Jordan +5 more
- Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and Clofazimine to Treat MDR-TBActive Not Recruiting
Sponsor: Boston University
Tuberculosis, Multidrug-Resistant
Philippines, Vietnam
Sponsor: Memorial Sloan Kettering Cancer Center
Non-small Cell Lung Cancer
United States
Sponsor: Novartis Pharmaceuticals
Breast Cancer
China
- A Phase I Study of JSB462 (Luxdegalutamide) in Japanese Patients With Metastatic Prostate CancerActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Metastatic Prostate Cancer (mCRPC)
Japan
Sponsor: Novartis Pharmaceuticals
Heart Failure With Reduced Ejection Fraction
United States, Canada
- A Study of Early Secukinumab Treatment in Moderate to Severe Hidradenitis Suppurativa PatientsNot Yet Recruiting
Sponsor: Novartis Pharmaceuticals
Hidradenitis Suppurativa
Sponsor: Novartis Pharmaceuticals
Systemic Lupus Erythematosus
United States, Argentina, Australia, Brazil, Bulgaria +24 more
Sponsor: Lan Coffman
Recurrent Ovarian Cancer
United States
Sponsor: M.D. Anderson Cancer Center
Head And Neck Cancer
United States
- Erlotinib and RAD001 (Everolimus) in Patients With Previously Treated Advanced Pancreatic CancerTerminated
Sponsor: M.D. Anderson Cancer Center
Pancreatic Cancer
United States
- Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant in Japanese Men and Postmenopausal Women With Advanced Breast CancerActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Advanced Breast Cancer
Japan
Sponsor: Novartis Pharmaceuticals
Breast Neoplasms · Carcinoma, Non-Small-Cell Lung
Netherlands
Sponsor: Novartis Pharmaceuticals
Relapsing Multiple Sclerosis
Portugal
Sponsor: University of Washington
Metastatic Castration-Resistant Prostate Carcinoma · Stage IVB Prostate Cancer AJCC v8
United States
Sponsor: Novartis Pharmaceuticals
Sjogren Syndrome
United States, Austria, Belgium, Brazil, Chile +13 more
- Trametinib in Combination With Paclitaxel in the Treatment of Anaplastic Thyroid CancerActive Not Recruiting
Sponsor: Memorial Sloan Kettering Cancer Center
Anaplastic Thyroid Cancer
United States
- A Clinical Trial to Learn About the Effects of VHB937 in People With Amyotrophic Lateral Sclerosis (ALS)Active Not Recruiting
Sponsor: Novartis Pharmaceuticals
Amyotrophic Lateral Sclerosis (ALS)
United States, Australia, Belgium, Canada, China +12 more
Sponsor: Novartis Pharmaceuticals
Metastatic Castration-resistant Prostate Cancer
South Korea